Minghua Ge

2.3k total citations
86 papers, 1.7k citations indexed

About

Minghua Ge is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Minghua Ge has authored 86 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 33 papers in Molecular Biology and 32 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Minghua Ge's work include Thyroid Cancer Diagnosis and Treatment (32 papers), Salivary Gland Tumors Diagnosis and Treatment (17 papers) and Thyroid and Parathyroid Surgery (11 papers). Minghua Ge is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (32 papers), Salivary Gland Tumors Diagnosis and Treatment (17 papers) and Thyroid and Parathyroid Surgery (11 papers). Minghua Ge collaborates with scholars based in China, United States and Japan. Minghua Ge's co-authors include Zhi‐Qiang Ling, Jun Cao, Zhuo Tan, Kejing Wang, Huizhang Li, Lingbin Du, Liang Xia, Caixing Sun, Youqing Wang and Fang Fěng and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Minghua Ge

85 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minghua Ge China 23 653 577 462 423 347 86 1.7k
Myriam Decaussin‐Petrucci France 24 642 1.0× 659 1.1× 462 1.0× 307 0.7× 399 1.1× 100 1.7k
Matthew A. Nehs United States 23 400 0.6× 848 1.5× 429 0.9× 432 1.0× 167 0.5× 54 1.5k
Ning Qu China 22 358 0.5× 623 1.1× 310 0.7× 283 0.7× 209 0.6× 64 1.2k
Shigeto Maeda Japan 18 536 0.8× 656 1.1× 299 0.6× 535 1.3× 183 0.5× 63 1.5k
Qinghai Ji China 24 339 0.5× 994 1.7× 638 1.4× 262 0.6× 215 0.6× 66 1.5k
Wenwu Dong China 24 852 1.3× 779 1.4× 451 1.0× 167 0.4× 657 1.9× 75 1.8k
John E. Phay United States 24 574 0.9× 1.2k 2.1× 1.3k 2.8× 321 0.8× 260 0.7× 71 2.6k
Ginesa García‐Rostán Spain 20 765 1.2× 1.2k 2.0× 237 0.5× 636 1.5× 189 0.5× 27 1.9k
Rengyun Liu China 21 1.2k 1.8× 1.5k 2.6× 288 0.6× 737 1.7× 373 1.1× 55 2.6k

Countries citing papers authored by Minghua Ge

Since Specialization
Citations

This map shows the geographic impact of Minghua Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghua Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghua Ge more than expected).

Fields of papers citing papers by Minghua Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minghua Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghua Ge. The network helps show where Minghua Ge may publish in the future.

Co-authorship network of co-authors of Minghua Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Minghua Ge. A scholar is included among the top collaborators of Minghua Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minghua Ge. Minghua Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Minghua, Xuan-Yu Chen, Ping Huang, et al.. (2025). Understanding and overcoming multidrug resistance in cancer. Nature Reviews Clinical Oncology. 22(10). 760–780. 10 indexed citations
2.
Zhang, Yining, Zhenfang Li, Yanting Duan, et al.. (2024). Recent advances of photodiagnosis and treatment for head and neck squamous cell carcinoma. Neoplasia. 60. 101118–101118. 6 indexed citations
3.
Du, Mi, Ke Deng, Qingqing Cai, et al.. (2023). Mediating role of systemic inflammation in the association between heavy metals exposure and periodontitis risk. Journal of Periodontology. 95(5). 502–514. 7 indexed citations
4.
Zhang, Wenchao, Hongyan Jiang, Rongqiao He, et al.. (2023). Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis. Journal of Endocrinological Investigation. 47(6). 1513–1530. 7 indexed citations
5.
6.
Zhang, Bei, et al.. (2022). Recent advances in the development of EGFR degraders: PROTACs and LYTACs. European Journal of Medicinal Chemistry. 239. 114533–114533. 36 indexed citations
7.
Zheng, Xiangqian, Zhengang Xu, Qinghai Ji, et al.. (2021). A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer. Clinical Cancer Research. 27(20). 5502–5509. 31 indexed citations
8.
9.
Chi, Yihebali, Ming Gao, Feng Shi, et al.. (2020). LBA88 Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial. Annals of Oncology. 31. S1215–S1215. 6 indexed citations
10.
Li, Qinglin, Xiaoxuan Fu, Xinyang Ge, et al.. (2019). Antitumor Effects and Related Mechanisms of Ethyl Acetate Extracts of Polygonum perfoliatum L.. Frontiers in Oncology. 9. 578–578. 9 indexed citations
11.
12.
Cao, Jun, et al.. (2018). Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma. Human Pathology. 81. 105–112. 14 indexed citations
13.
Zhou, Lingyan, et al.. (2018). Breast cancer metastasis to thyroid: a retrospective analysis. African Health Sciences. 17(4). 1035–1035. 20 indexed citations
14.
Zheng, Chuanming, et al.. (2017). [The bisphenol A-enhanced activity of thyroid carcinoma cell line B-CPAP is inhibited by Icarrin].. PubMed. 52(6). 458–462. 5 indexed citations
15.
Tan, Zhou, et al.. (2017). Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. BMC Cancer. 17(1). 702–702. 45 indexed citations
16.
Ge, Minghua, Meng Shi, Changming An, et al.. (2016). Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma. Scientific Reports. 6(1). 26037–26037. 27 indexed citations
17.
Wang, Jiafeng, et al.. (2012). [Clinical analysis of 52 cases of adenoid cystic carcinoma in minor salivary gland].. PubMed. 47(12). 705–10. 3 indexed citations
18.
Shang, Jinbiao, et al.. (2012). Analysis of prognostic risk factors and treatment of parotid cancer. Oncology Letters. 3(6). 1307–1310. 8 indexed citations
19.
Jiang, Youhua, Bo Cheng, Minghua Ge, & Gu Zhang. (2012). The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma. Head & Neck Oncology. 4(1). 9–9. 15 indexed citations
20.
Mao, Weimin, et al.. (2011). Hypermethylation-modulated Downregulation of RASSF1A Expression Is Associated with the Progression of Esophageal Cancer. Archives of Medical Research. 42(3). 182–188. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myriam Decaussin‐Petrucci Breakdown of academic impact, for papers by Matthew A. Nehs Breakdown of academic impact, for papers by Ning Qu Breakdown of academic impact, for papers by Shigeto Maeda Breakdown of academic impact, for papers by Qinghai Ji Breakdown of academic impact, for papers by Wenwu Dong Breakdown of academic impact, for papers by John E. Phay Breakdown of academic impact, for papers by Ginesa García‐Rostán Breakdown of academic impact, for papers by Rengyun Liu
Rankless by CCL
2026